Journal of Clinical Medicine (Aug 2022)

Assessment of the Effect on Thromboprophylaxis with Multifaceted Quality Improvement Intervention based on Clinical Decision Support System in Hospitalized Patients: A Pilot Study

  • Qian Gao,
  • Kaiyuan Zhen,
  • Lei Xia,
  • Wei Wang,
  • Yaping Xu,
  • Chaozeng Si,
  • Zhu Zhang,
  • Fen Dong,
  • Jieping Lei,
  • Peiran Yang,
  • Jixiang Liu,
  • Ziyi Sun,
  • Tieshan Zhang,
  • Jun Wan,
  • Wanmu Xie,
  • Peng Liu,
  • Cunbo Jia,
  • Zhenguo Zhai,
  • Chen Wang

DOI
https://doi.org/10.3390/jcm11174997
Journal volume & issue
Vol. 11, no. 17
p. 4997

Abstract

Read online

Background: To explore the feasibility and effectiveness of multifaceted quality improvement intervention based on the clinical decision support system (CDSS) in VTE prophylaxis in hospitalized patients. Methods: A randomized, department-based clinical trial was conducted in the department of respiratory and critical care medicine, orthopedic, and general surgery wards. Patients aged ≥18 years, without VTE in admission, were allocated to the intervention group and received regular care combined with multifaceted quality improvement intervention based on CDSS during hospitalization. VTE prophylaxis rate and the occurrence of hospital-associated VTE events were analyzed as primary and secondary outcomes. Results: A total of 3644 eligible residents were enrolled in this trial. With the implementation of the multifaceted quality improvement intervention based on the CDSS, the VTE prophylaxis rate of the intervention group increased from 22.93% to 34.56% (p p = 0.366). In the nonintervention group, the VTE prophylaxis rate increased from 24.49% to 27.90% (p = 0.091), and the incidence of HA-VTE events increased from 0.47% to 2.02% (p = 0.001). Conclusions: Multifaceted quality improvement intervention based on the CDSS strategy is feasible and expected to facilitate implementation of the recommended VTE prophylaxis strategies and reduce the incidence of HA-VTE in hospital. However, it is necessary to conduct more multicenter clinical trials in the future to provide more reliable real-world evidence.

Keywords